Attenuated live vaccine

Details for Australian Patent Application No. 2002229390 (hide)

Owner Intercell AG

Inventors Heinz, Franz, X.; Mandl, Christian

Agent Davies Collison Cave

Pub. Number AU-B-2002229390

PCT Pub. Number WO2002/066621

Priority A 272/2001 21.02.01 AT

Filing date 11 February 2002

Wipo publication date 4 September 2002

Acceptance publication date 16 March 2006

International Classifications

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 15/40 (2006.01) Mutation or genetic engineering - Proteins from RNA viruses, e.g. flaviviruses

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-B-2002229390

22 December 2005 Assignment before Grant

  Heinz, Franz; Mandl, Christian The application has been assigned to Intercell AG

16 March 2006 Application Accepted

  Published as AU-B-2002229390

13 July 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002229391-METHOD AND DEVICE FOR FORWARDING SHORT MESSAGES FROM A MOBILE TERMINAL

2002229389-BIOARTIFICIAL DEVICE FOR STORING, CULTIVATING AND/OR REPRODUCING CELLS